Treating Cancer as Patients Age
As patients aged 65 or older receive a diagnosis of cancer, their treatment course and priorities may differ from their younger counterparts.
Peer Support Helps Patients Navigate Their Cancer Journey
Katie Brown, senior vice president of survivorship and support for LUNGevity Foundation, wrote about a program for patients to gain knowledge from survivors.
Aiming for New Targets: Emerging Therapies in Melanoma
In its Speaking Out video series, on behalf of Aim at Melanoma, CURE ® spoke with Dr. Sunandana Chandra about emerging therapies in melanoma.
Pet Companionship During the Cancer Journey
Having a pet to care for may motivate patients to exercise and be positive when undergoing cancer treatment.
Recognizing Cancer Fate Without Losing Control
Patients and their caregivers can navigate a terminal cancer diagnosis while keeping dignity intact.
‘No One-Size-Fits-All’ First-Line Treatment for Mantle Cell Lymphoma
Patients can now prioritize whether durable responses to treatment or avoiding certain side effects are more valuable to them.
Matchmakers: How Basket Trials Match Patients With Drugs Based on Their Tumors
Increasingly, researchers are playing matchmaker between patients with metastatic cancer and targeted drugs via studies called basket trials.
Too Much Money for the Medicine
Newer cancer therapies easily cost upward of $100,000. Why so much? Who sets the prices and what can patients do if they can't afford them?
2 Commerce Drive Cranbury, NJ 08512